Also, (Cloer et al. 2019) reported that the NRF2–KEAP1 signaling pathway could be activated through protein–protein interaction to suppress cancer-associated risk factors such as xenobiotic efflux, cellular resistance to oxidative stress, metabolic reprogramming, and proliferation. This evidence concerns the gene NFE2L2 and cancer.